CC BY-NC-ND 4.0 · South Asian J Cancer 2022; 11(01): 040-045
DOI: 10.1055/s-0041-1740600
Original Article
Gynaecological Cancer

Prognostic Factors of Granulosa Cell Tumors: A Retrospective Study in a Tertiary Care Cancer Centre of Eastern India

Rohini V. Kulkarni
1   Department of Gynaecological Oncology, Acharya Harihar Regional Cancer Centre, Cuttack, India
,
Bhagyalaxmi Nayak
1   Department of Gynaecological Oncology, Acharya Harihar Regional Cancer Centre, Cuttack, India
,
Jita Parija
1   Department of Gynaecological Oncology, Acharya Harihar Regional Cancer Centre, Cuttack, India
,
Janmejaya Mohapatra
1   Department of Gynaecological Oncology, Acharya Harihar Regional Cancer Centre, Cuttack, India
,
Manoranjan Mohapatra
1   Department of Gynaecological Oncology, Acharya Harihar Regional Cancer Centre, Cuttack, India
,
Ashok Padhy
1   Department of Gynaecological Oncology, Acharya Harihar Regional Cancer Centre, Cuttack, India
› Author Affiliations

Abstract

Zoom Image
Bhagyalaxmi Nayak

Background and Aims The main objective of this study was to analyze the clinicopathological profile and prognostic factors of granulosa cell tumor (GCT).

Method All the cases of ovarian cancer which were seen at our institute between January 2000 and December 2017 were reviewed. Data were analyzed with failure-free survival (FFS) as the primary end point.

Results GCTs consisted of 2.66% of all ovarian cancers at our institute. The median age was 43 years. Majority of the patients (62.5%) were unstaged. Six patients (25%) had a fertility-preserving procedure. Forty two percent of the patients received adjuvant chemotherapy. Thirty eight percent of the patients developed recurrence. Considering tumor-related prognostic factors, there was a statistically significant decrease in FFS with the presence of hemorrhage (p = < 0.001), larger tumors (p = 0.042), and juvenile variant (p = 0.002). On the contrary, when treatment-related factors were considered, there was no statistically significant improvement in FFS with the performance of lymphadenectomy (p = 0.218), omentectomy (p = 0.453), fertility sparing surgery (p = 0.152), or administration of adjuvant chemotherapy (p = 0.45).

Conclusion Inherent tumor-related biological factors tend to play a more important role compared with treatment-related factors in GCTs. Hence, the traditional practice of performance of extensive staging procedures and routine adjuvant chemotherapy should be reviewed. Fertility-preserving surgery appears safe to be offered in early stages when desired. Although it is common knowledge that GCTs tend to be hemorrhagic tumors, this factor has not been well recognized as a prognostic indicator till date. Our study sheds some light on this aspect. Since these tumors have a tendency toward late recurrences, a long follow-up is prudent.

Source of Support

None.




Publication History

Article published online:
02 February 2022

© 2022. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Quirk JT, Natarajan N. Ovarian cancer incidence in the United States, 1992-1999. Gynecol Oncol 2005; 97 (02) 519-523
  • 2 Schumer ST, Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol 2003; 21 (06) 1180-1189
  • 3 Willemsen W, Kruitwagen R, Bastiaans B, Hanselaar T, Rolland R. Ovarian stimulation and granulosa-cell tumour. Lancet 1993; 341 (8851): 986-988
  • 4 Unkila-Kallio L, Tiitinen A, Wahlström T, Lehtovirta P, Leminen A. Reproductive features in women developing ovarian granulosa cell tumour at a fertile age. Hum Reprod 2000; 15 (03) 589-593
  • 5 East N, Alobaid A, Goffin F, Ouallouche K, Gauthier P. Granulosa cell tumour: a recurrence 40 years after initial diagnosis. J Obstet Gynaecol Can 2005; 27 (04) 363-364
  • 6 Auranen A, Sundström J, Ijäs J, Grénman S. Prognostic factors of ovarian granulosa cell tumor: a study of 35 patients and review of the literature. Int J Gynecol Cancer 2007; 17 (05) 1011-1018
  • 7 Uygun K, Aydiner A, Saip P. et al. Granulosa cell tumor of the ovary: retrospective analysis of 45 cases. Am J Clin Oncol 2003; 26 (05) 517-521
  • 8 Seagle BL, Ann P, Butler S, Shahabi S. Ovarian granulosa cell tumor: a National Cancer Database study. Gynecol Oncol 2017; 146 (02) 285-291
  • 9 Meisel JL, Hyman DM, Jotwani A. et al. The role of systemic chemotherapy in the management of granulosa cell tumors. Gynecol Oncol 2015; 136 (03) 505-511
  • 10 Sakr S, Al-Wahab Z, Abdulfatah E. et al. Granulosa cell tumors: A SEER data review of prognostic parameters in 1815 patients. Gynecol Oncol 2017; 145 (Suppl. 01) 127
  • 11 Park JY, Jin KL, Kim DY. et al. Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary. Gynecol Oncol 2012; 125 (01) 80-86
  • 12 Thrall MM, Paley P, Pizer E, Garcia R, Goff BA. Patterns of spread and recurrence of sex cord-stromal tumors of the ovary. Gynecol Oncol 2011; 122 (02) 242-245
  • 13 Brown J, Sood AK, Deavers MT, Milojevic L, Gershenson DM. Patterns of metastasis in sex cord-stromal tumors of the ovary: can routine staging lymphadenectomy be omitted?. Gynecol Oncol 2009; 113 (01) 86-90
  • 14 Iavazzo C, Gkegkes ID, Vrachnis N. Fertility sparing management and pregnancy in patients with granulosa cell tumour of the ovaries. J Obstet Gynaecol 2015; 35 (04) 331-335
  • 15 National Comprehensive Cancer Network. Ovarian cancer (version 2. 2018 ). Accessed on July 20, 2018 at: http://www.nccn.org/professionals/physician_gls/pdf/ovarian.pdf
  • 16 Sigismondi C, Gadducci A, Lorusso D. et al. Ovarian Sertoli-Leydig cell tumors: a retrospective MITO study. Gynecol Oncol 2012; 125 (03) 673-676
  • 17 Shavit T, Bruchim I, Ben-Harim Z, Fishman A. Successful response to docetaxel treatment in recurrent ovarian granulosa cell tumor: a case report. Eur J Gynaecol Oncol 2012; 33 (04) 419-420
  • 18 Savage P, Constenla D, Fisher C. et al. Granulosa cell tumours of the ovary: demographics, survival and the management of advanced disease. Clin Oncol (R Coll Radiol) 1998; 10 (04) 242-245
  • 19 Li W, Wu X, Fang C, Yao J, Guo Y, Zhang S. Prognostic factors in adult granulosa cell tumor of the ovary. Saudi Med J 2009; 30 (02) 247-252
  • 20 Chiara S, Merlini L, Campora E. et al. Cisplatin-based chemotherapy in recurrent or high risk ovarian granulosa-cell tumor patients. Eur J Gynaecol Oncol 1993; 14 (04) 314-317
  • 21 Al-Badawi IA, Brasher PM, Ghatage P, Nation JG, Schepansky A, Stuart GC. Postoperative chemotherapy in advanced ovarian granulosa cell tumors. Int J Gynecol Cancer 2002; 12 (01) 119-123
  • 22 Zanagnolo V, Pasinetti B, Sartori E. Clinical review of 63 cases of sex cord stromal tumors. Eur J Gynaecol Oncol 2004; 25 (04) 431-438
  • 23 Gurumurthy M, Bryant A, Shanbhag S. Effectiveness of different treatment modalities for the management of adult-onset granulosa cell tumours of the ovary (primary and recurrent). Cochrane Database Syst Rev 2014; 4 (04) CD006912
  • 24 Sun HD, Lin H, Jao MS. et al. A long-term follow-up study of 176 cases with adult-type ovarian granulosa cell tumors. Gynecol Oncol 2012; 124 (02) 244-249
  • 25 Lee IH, Choi CH, Hong DG. et al. Clinicopathologic characteristics of granulosa cell tumors of the ovary: a multicenter retrospective study. J Gynecol Oncol 2011; 22 (03) 188-195
  • 26 Chan JK, Zhang M, Kaleb V. et al. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary–a multivariate analysis. Gynecol Oncol 2005; 96 (01) 204-209
  • 27 Mangili G, Ottolina J, Gadducci A. et al. Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary. Br J Cancer 2013; 109 (01) 29-34